144 related articles for article (PubMed ID: 18082160)
1. 5-Fluorotryptamine is a partial agonist at 5-HT3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function.
Bower KS; Price KL; Sturdee LE; Dayrell M; Dougherty DA; Lummis SC
Eur J Pharmacol; 2008 Feb; 580(3):291-7. PubMed ID: 18082160
[TBL] [Abstract][Full Text] [Related]
2. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
3. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
4. Subtle Differences among 5-HT
Price KL; Hirayama Y; Lummis SCR
ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of sterically fixed tryptamine and 5-methoxytryptamine derivatives for serotonin receptor subtypes, II: Structure-activity relationships and in vitro pharmacology of N-alkyl- and N,N-dialkyl-3- indolylbicyclo-[2.2.1]-heptane-2-amines.
Elz S; Zimmermann H; Rehse K
Arch Pharm (Weinheim); 1993 Nov; 326(11):893-9. PubMed ID: 8274071
[TBL] [Abstract][Full Text] [Related]
6. Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig.
Villalón CM; den Boer MO; Heiligers JP; Saxena PR
Br J Pharmacol; 1991 Jan; 102(1):107-12. PubMed ID: 2043916
[TBL] [Abstract][Full Text] [Related]
7. Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.
Lummis SC; Thompson AJ; Bencherif M; Lester HA
J Pharmacol Exp Ther; 2011 Oct; 339(1):125-31. PubMed ID: 21775477
[TBL] [Abstract][Full Text] [Related]
8. Unraveling mechanisms underlying partial agonism in 5-HT3A receptors.
Corradi J; Bouzat C
J Neurosci; 2014 Dec; 34(50):16865-76. PubMed ID: 25505338
[TBL] [Abstract][Full Text] [Related]
9. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
10. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
11. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
14. SR 57227A is a partial agonist/partial antagonist of 5-HT
Nakamura Y; Kondo M; Koyama Y; Shimada S
Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
[TBL] [Abstract][Full Text] [Related]
15. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.
Nichols DE; Sassano MF; Halberstadt AL; Klein LM; Brandt SD; Elliott SP; Fiedler WJ
ACS Chem Neurosci; 2015 Jul; 6(7):1165-75. PubMed ID: 25547199
[TBL] [Abstract][Full Text] [Related]
16. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
17. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
18. The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Verheij MH; Verbeek J; Windhorst AD; de Esch IJ; Lummis SC
Neuropharmacology; 2014 Nov; 86():378-88. PubMed ID: 25174552
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
20. Importance of the C-terminus of the human 5-HT3A receptor subunit.
Butler AS; Lindesay SA; Dover TJ; Kennedy MD; Patchell VB; Levine BA; Hope AG; Barnes NM
Neuropharmacology; 2009 Jan; 56(1):292-302. PubMed ID: 18786552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
